Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.

Vaquero A, Scher MB, Lee DH, Sutton A, Cheng HL, Alt FW, Serrano L, Sternglanz R, Reinberg D.

Genes Dev. 2006 May 15;20(10):1256-61. Epub 2006 Apr 28.

2.

The molecular biology of mammalian SIRT proteins: SIRT2 in cell cycle regulation.

Inoue T, Hiratsuka M, Osaki M, Oshimura M.

Cell Cycle. 2007 May 2;6(9):1011-8. Epub 2007 May 30. Review.

PMID:
17457050
3.

Substrate specificity and kinetic mechanism of the Sir2 family of NAD+-dependent histone/protein deacetylases.

Borra MT, Langer MR, Slama JT, Denu JM.

Biochemistry. 2004 Aug 3;43(30):9877-87.

PMID:
15274642
4.

Histone deacetylase Rpd3 antagonizes Sir2-dependent silent chromatin propagation.

Zhou J, Zhou BO, Lenzmeier BA, Zhou JQ.

Nucleic Acids Res. 2009 Jun;37(11):3699-713. doi: 10.1093/nar/gkp233. Epub 2009 Apr 16.

5.
6.

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase.

Imai S, Armstrong CM, Kaeberlein M, Guarente L.

Nature. 2000 Feb 17;403(6771):795-800.

PMID:
10693811
7.

The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.

North BJ, Marshall BL, Borra MT, Denu JM, Verdin E.

Mol Cell. 2003 Feb;11(2):437-44.

8.
9.

Control of replication initiation by the Sum1/Rfm1/Hst1 histone deacetylase.

Weber JM, Irlbacher H, Ehrenhofer-Murray AE.

BMC Mol Biol. 2008 Nov 6;9:100. doi: 10.1186/1471-2199-9-100.

10.

SIR2-induced inviability is suppressed by histone H4 overexpression.

Matecic M, Stuart S, Holmes SG.

Genetics. 2002 Oct;162(2):973-6.

11.
12.

Nuclear export modulates the cytoplasmic Sir2 homologue Hst2.

Wilson JM, Le VQ, Zimmerman C, Marmorstein R, Pillus L.

EMBO Rep. 2006 Dec;7(12):1247-51. Epub 2006 Nov 17.

13.

Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.

Dryden SC, Nahhas FA, Nowak JE, Goustin AS, Tainsky MA.

Mol Cell Biol. 2003 May;23(9):3173-85.

14.

Human Sir2 and the 'silencing' of p53 activity.

Smith J.

Trends Cell Biol. 2002 Sep;12(9):404-6.

PMID:
12220851
15.

Acetylation of Sirt2 by p300 attenuates its deacetylase activity.

Han Y, Jin YH, Kim YJ, Kang BY, Choi HJ, Kim DW, Yeo CY, Lee KY.

Biochem Biophys Res Commun. 2008 Oct 31;375(4):576-80. doi: 10.1016/j.bbrc.2008.08.042. Epub 2008 Aug 21.

PMID:
18722353
17.

NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

Vaquero A, Sternglanz R, Reinberg D.

Oncogene. 2007 Aug 13;26(37):5505-20. Review.

PMID:
17694090
18.

Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin.

Nahhas F, Dryden SC, Abrams J, Tainsky MA.

Mol Cell Biochem. 2007 Sep;303(1-2):221-30. Epub 2007 May 22.

PMID:
17516032
19.

SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction.

Wang F, Nguyen M, Qin FX, Tong Q.

Aging Cell. 2007 Aug;6(4):505-14. Epub 2007 May 23.

20.

Differential regulation of the Sir2 histone deacetylase gene family by inhibitors of class I and II histone deacetylases.

Kyrylenko S, Kyrylenko O, Suuronen T, Salminen A.

Cell Mol Life Sci. 2003 Sep;60(9):1990-7.

PMID:
14523559

Supplemental Content

Support Center